HOME >> MEDICINE >> NEWS
Shire's DAYTRANA(TM) transdermal patch approved by FDA for treatment of ADHD

Philadelphia, PA, US and Basingstoke, UK -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the U.S. Food and Drug Administration (FDA) approved DAYTRANA (methylphenidate transdermal system), the first and only non-oral medication for the treatment of attention deficit hyperactivity disorder (ADHD). DAYTRANA, a once daily transdermal patch formulation of methylphenidate, will be available in 10 mg, 15 mg, 20 mg and 30 mg dosage strengths.

"The approval of DAYTRANA is important news for ADHD patients, their families and healthcare providers. In addition to being the only patch treatment for ADHD, it offers a convenient option to deliver medicine for those diagnosed with ADHD," said Shire Chief Executive Officer Matthew Emmens. "The addition of DAYTRANA to Shire's portfolio reaffirms our position as the market leader in ADHD."

Shire and Noven Pharmaceuticals, Inc. submitted an amended New Drug Application (NDA) for DAYTRANA to the FDA in June of last year. DAYTRANA is licensed globally to Shire by Noven and will be available in pharmacies in the U.S. in mid 2006.

The efficacy of DAYTRANA was established in two controlled clinical trials in children aged 6 to 12 years old with ADHD. DAYTRANA combines methylphenidate, a medication with a 50-year history of use, with Noven's patented DOT Matrix transdermal technology. This transdermal delivery system delivers medication directly through the skin into the bloodstream, and is designed to provide consistent, smooth drug release throughout the day. The patch is designed to stay on during the normal daily activities of a child, including swimming, exercising, and bathing. Because DAYTRANA is a patch, physicians can manage the duration of its effect and potential side effects by having the patient wear the patch for a shorter time period than the recommended 9 hour wear time on a given day. In clinical trials, wearing a DAYTRANA patch for 9 hours provided a duration of
'"/>

Contact: Matthew Cabrey, Shire
MCabrey@us.shire.com
484-595-8248
Porter Novelli
7-Apr-2006


Page: 1 2 3

Related medicine news :

1. Shires DAYTRANA, first patch medication for ADHD in children, now available in pharmacies
2. DAYTRANA (methylphenidate transdermal system) significant reduces ADHD symptoms
3. Positive study results for methylphenidate transdermal system
4. Positive study results for methylphenidate transdermal system
5. Four new us patents granted to Acrux for transdermal drug delivery
6. Novel catheter technique successfully patches holes in the heart
7. CankerMelts patches reduce pain and speed resolution of canker sores
8. Blood test predicts success of quitting smoking using the nicotine patch
9. Decent NHS care for older people still too patchy
10. Do testosterone patches help women with under-active pituitary glands?
11. Fentanyl patch safe and effective alternative to oral opioids for pediatric pain patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... ... August 21, 2019 , ... ... automated x-ray inspection technology: HDRX imaging. HDRX captures extremely high-resolution images of ... HDRX can deliver high image resolution at normal production line speeds within ...
(Date:8/19/2019)... ... August 19, 2019 , ... AJG Packaging, ... announced the availability of resealable single-dose vials for a multitude of applications. The ... consists of five resealable breakaway vials and are available in either polyethylene or ...
(Date:8/19/2019)... ... August 19, 2019 , ... American ... necessary and cosmetic procedures in 2018 – 7.5 percent more than 2017 and ... 2018 ASDS Survey on Dermatologic Procedures revealed skin cancer treatments are ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... and San Antonio, Texas, proudly announces they have ranked #3056 on the 2019 ... and represents a unique look at the most successful companies within the American ...
(Date:8/19/2019)... NEW YORK (PRWEB) , ... August 19, 2019 , ... ... turning the spotlight on the best hair restoration doctors in New York currently providing ... as well as those starting to see some thinning hair. Cosmetic Town makes the ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... , ... August 21, 2019 , ... ... experience by lowering pool chemical use with Clear Comfort’s Advanced Oxidation Process (AOP) ... to save significant chemical expense dollars, simplify its water care protocol and improve ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... hosting their 2nd Annual National Sports Summit, August 25-26 at the Hyatt Place ... clinical leaders from all major professional sports programs to discuss progress made over ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... announced the findings of research validating the clinical impact of MedAware’s machine learning-enabled ... 7 August 2019 in the Journal of American Medical Informatics Association (JAMIA) ...
Breaking Medicine Technology:
Cached News: